Bayer AG (BAYRY)
7.08
+0.04
(+0.57%)
USD |
OTCM |
Apr 19, 16:00
Bayer Cash from Operations (TTM): 5.540B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 5.540B |
September 30, 2023 | 2.885B |
June 30, 2023 | 2.669B |
March 31, 2023 | 4.482B |
December 31, 2022 | 7.480B |
September 30, 2022 | 7.674B |
June 30, 2022 | 8.415B |
March 31, 2022 | 8.538B |
December 31, 2021 | 6.021B |
September 30, 2021 | 3.153B |
June 30, 2021 | 2.267B |
March 31, 2021 | 2.520B |
December 31, 2020 | 5.599B |
September 30, 2020 | 8.527B |
June 30, 2020 | 8.585B |
March 31, 2020 | 7.709B |
December 31, 2019 | 9.188B |
September 30, 2019 | 9.110B |
June 30, 2019 | 8.898B |
March 31, 2019 | 9.766B |
December 31, 2018 | 9.348B |
September 30, 2018 | 8.071B |
June 30, 2018 | 9.202B |
March 31, 2018 | 9.124B |
December 31, 2017 | 9.212B |
Date | Value |
---|---|
September 30, 2017 | 9.859B |
June 30, 2017 | 9.797B |
March 31, 2017 | 9.497B |
December 31, 2016 | 10.06B |
September 30, 2016 | 9.170B |
June 30, 2016 | 8.414B |
March 31, 2016 | 8.287B |
December 31, 2015 | 7.646B |
September 30, 2015 | 8.553B |
June 30, 2015 | 8.272B |
March 31, 2015 | 8.320B |
December 31, 2014 | 7.726B |
September 30, 2014 | 6.852B |
June 30, 2014 | 6.854B |
March 31, 2014 | 6.659B |
December 31, 2013 | 6.868B |
September 30, 2013 | 6.053B |
June 30, 2013 | 6.154B |
March 31, 2013 | 5.945B |
December 31, 2012 | 5.824B |
September 30, 2012 | 6.062B |
June 30, 2012 | 5.800B |
March 31, 2012 | 6.270B |
December 31, 2011 | 7.055B |
September 30, 2011 | 8.226B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
2.267B
Minimum
Jun 2021
9.188B
Maximum
Dec 2019
6.277B
Average
7.480B
Median
Dec 2022
Cash from Operations (TTM) Benchmarks
Regeneron Pharmaceuticals Inc | 4.594B |
Affimed NV | -119.38M |
InflaRx NV | -40.94M |
MorphoSys AG | -- |
BioNTech SE | 5.815B |